CLINICAL_TRIALS
trial_result
· 2025-02-18
Clinical Trial Update: Phase 2 Clinical Trial of GH001 in Bipolar II Disorder [Phase 2]
Summary
A Phase 2 study of GH001 in Bipolar II Disorder has been terminated, ending the trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GH Research Ireland Limited | Conditions: Bipolar II Disorder | Phase 2 | Status: TERMINATED